The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology

By /

The clearest demonstration, yet, of the value – to patients – of precision medicine in oncology.

with permission, Maria Schwaederle, PharmD
ASCO presentation, June 2016 as seen in Forbes
Scroll to Top